News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER Research Update: March 2026
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
Feature
59 Results
59 Results
R3 Seminar Recap: Understanding metformin use and Long COVID and ME/CFS following COVID-19 infection: Insights from two studies
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
R3 Seminar Recap
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
RECOVER Representatives help inform and raise awareness about RECOVER research
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.
Feature
RECOVER study examines how a person’s sex impacts Long COVID risk
A recent RECOVER study found that women had a 31% higher risk for developing Long COVID than men. Findings from this study may help identify who is at a higher risk for developing Long COVID and potential Long COVID treatments.
Feature
RECOVER Representatives inform Long COVID research through authorship
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
Feature
R3 Seminar Recap: Ethical considerations for enrolling “invested parties” in large-scale clinical studies: Insights from the RECOVER Initiative
During the January 28th RECOVER Research Review (R3) Seminar, Dr. Kellie Owens, PhD (NYU Grossman School of Medicine) shared ethical guidance for enrolling individuals in clinical studies who have direct involvement with the research. Dr. Owens was joined by co-authors Leah Castro, MA (RECOVER Community and Caregiver Representative) and Rebecca Letts (RECOVER Patient and Caregiver Representative), who described Representatives’ important role in designing RECOVER clinical studies and developing peer-reviewed research publications.
R3 Seminar Recap
RECOVER study finds COVID-19 increases risk of developing ME/CFS
RECOVER researchers found that people were more likely to develop myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after having COVID-19. Most of the people who developed ME/CFS also developed Long COVID.
Feature
A person’s sex may affect their risk of developing Long COVID
Some women taking part in RECOVER research were more likely to experience Long COVID compared to men.
Announcement